Natrixam (Indapamide, Amlodipine Besilate)

Indapamide, the active ingredient in Natrixam, is a combination diuretic and calcium‑channel blocker presented as an oral tablet for systemic use. It is indicated for the management of elevated blood pressure in adult patients, employing complementary actions that lower plasma volume and relax arterial smooth muscle to achieve effective antihypertensive control.

GNH USA supplies Natrixam as a licensed, GDP‑compliant international pharmaceutical product, providing reliable and timely access to hospitals, pharmacies and clinics worldwide through regulated supply chains and quality‑assured manufacturing practices.

Natrixam is used to treat hypertension, a condition characterized by chronically elevated arterial pressure.

- Essential hypertension: lowers systolic and diastolic blood pressure. - Hypertension with peripheral edema: reduces fluid retention while controlling pressure. - Hypertension requiring calcium‑channel blockade: adds arterial vasodilation to diuretic‑induced volume reduction.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness, especially after standing. - Peripheral edema: swelling of ankles or feet. - Flushing or warmth sensation. - Fatigue or general weakness. - Nausea or mild gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure. - Electrolyte disturbances: especially low potassium or sodium. - Acute renal impairment or worsening kidney function. - Angioedema: swelling of face, lips, or throat. - Hepatic injury: elevated liver enzymes or jaundice. - Cardiac arrhythmias: irregular heart rhythms.

Before initiating therapy, clinicians should assess individual risk factors and monitor relevant parameters. - Blood pressure monitoring: ensure adequate control without excessive lowering. - Renal function: evaluate creatinine and eGFR periodically. - Electrolyte balance: check serum potassium and sodium levels. - Hepatic impairment: use with caution in patients with liver disease. - Hypersensitivity: discontinue if allergic reactions occur. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Drug interactions may modify efficacy or increase toxicity and should be reviewed before prescribing. Major Interactions (Avoid): - Concurrent use with other potent diuretics: may cause excessive volume depletion. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase amlodipine plasma concentrations. - Potassium‑sparing diuretics or supplements: risk of hyperkalemia. Moderate Interactions (Monitor Closely):\n- Other antihypertensives (ACE inhibitors, ARBs, beta‑blockers): may enhance blood pressure lowering. - Lithium therapy: increased lithium levels and potential toxicity. - Digoxin: possible rise in digoxin concentrations.